Aspira women's health announces the addition of 465,000 covered lives through medicaid credentialing

Austin, texas, jan. 31, 2022 (globe newswire) -- aspira women's health, inc. (nasdaq: awh), a bioanalytical-based women's health company, announced today that it has entered into agreements to provide its testing services to medicaid plan members in the state of new hampshire and washington, d.c equaling nearly a half million covered lives. the state of new hampshire covers 200,000 lives and washington d.c. covers 265,000 lives under their respective medicaid programs. with the addition of these plans, aspira is now credentialed to provide its ova1 testing to nearly 80% of the medicaid population in the u.s., totaling approximately 60 million lives.
AWH Ratings Summary
AWH Quant Ranking